Onaiza Cadoret-Manier
Direktor/Vorstandsmitglied bei ARDELYX, INC.
Vermögen: 2 Mio $ am 31.05.2024
Profil
Onaiza Cadoret-Manier is currently the Chief Executive Officer at Stealth Mode Biotech since 2024.
She is also an Independent Director at Ardelyx, Inc. since 2020 and at Ventyx Biosciences, Inc. since 2023.
Previously, she held the position of Vice President-Respiratory Franchise at Genentech, Inc. from 2011 to 2018.
She also served as the Chief Commercial Officer at GRAIL LLC and Grail Biosciences from 2018 to 2019.
From 2020 to 2024, she was the EVP, Chief Product Strategy & Operations Officer at Ionis Pharmaceuticals, Inc. Ms. Cadoret-Manier completed her undergraduate degree at Queens College in 1985 and obtained an MBA from The University of Chicago in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 35 825 ( 0,02% ) | 1 Mio $ | 31.05.2024 | |
ARDELYX, INC.
0,05% | 15.04.2024 | 110 150 ( 0,05% ) | 755 629 $ | 31.05.2024 |
VENTYX BIOSCIENCES, INC.
-.--% | 06.06.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Onaiza Cadoret-Manier
| Unternehmen | Position | Beginn |
|---|---|---|
| ARDELYX, INC. | Direktor/Vorstandsmitglied | 12.03.2020 |
| VENTYX BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.01.2023 |
Ehemalige bekannte Positionen von Onaiza Cadoret-Manier
| Unternehmen | Position | Ende |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Geschäftsführer | 15.03.2024 |
GRAIL LLC
 GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01.05.2019 |
| Grail Biosciences | Corporate Officer/Principal | 01.01.2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2018 |
Ausbildung von Onaiza Cadoret-Manier
| Queens College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
| Grail Biosciences |
